If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sang-Min Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 35 Similar Profiles
Chronic Obstructive Pulmonary Disease Medicine & Life Sciences
Lung Medicine & Life Sciences
Republic of Korea Medicine & Life Sciences
Korea Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Tertiary Care Centers Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

  • 2418 Citations
  • 25 h-Index
  • 150 Article
  • 4 Review article
  • 3 Letter
  • 2 Comment/debate
1 Citation (Scopus)

Serum Uric Acid Level as a Prognostic Marker in Patients With Acute Respiratory Distress Syndrome

Lee, H. W., Choi, S. M., Lee, J., Park, Y. S., Lee, C. H., Yim, J-J., Yoo, C. G., Kim, Y., Han, S. & Lee, S-M., 1 May 2019, In : Journal of Intensive Care Medicine. 34, 5, p. 404-410 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Adult Respiratory Distress Syndrome
Uric Acid
Serum
Propensity Score
Kaplan-Meier Estimate
1 Citation (Scopus)

Improvement in the survival rates of extracorporeal membrane oxygenation-supported respiratory failure patients: a multicenter retrospective study in Korean patients: A multicenter retrospective study in Korean patients 11 Medical and Health Sciences 1103 Clinical Sciences

Baek, M. S., Lee, S-M., Chung, C. R., Cho, W. H., Cho, Y. J., Park, S., Koo, S. M., Jung, J. S., Park, S. Y., Chang, Y., Kang, B. J., Kim, J. H., Oh, J. Y., Park, S. H., Yoo, J. W., Sim, Y. S. & Hong, S. B., 3 Jan 2019, In : Critical Care. 23, 1, p. 1 1.

Research output: Contribution to journalArticleResearchpeer-review

Extracorporeal Membrane Oxygenation
Respiratory Insufficiency
Multicenter Studies
Survival Rate
Retrospective Studies
5 Citations (Scopus)

Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial

Lee, J. K., Lee, J. Y., Kim, D. K., Yoon, H. I., Jeong, I., Heo, E. Y., Park, Y. S., Jo, Y. S., Lee, J. H., Park, S. S., Park, J. S., Kim, J., Lee, S-M., Joh, J. S., Lee, C. H., Lee, J., Choi, S. M., Park, J. H., Lee, S. H., Cho, Y. J. & 15 others, Lee, Y. J., Kim, S., Kwak, N., Hwang, Y. R., Kim, H., Ki, J., Lim, J. N., Choi, H. S., Lee, M., Song, T., Kim, H. S., Han, J., Ahn, H., Hahn, S. & Yim, J-J., 1 Jan 2019, In : The Lancet Infectious Diseases. 19, 1, p. 46-55 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Linezolid
Ethambutol
Pulmonary Tuberculosis
Therapeutics
Sputum
Bronchitis
Chronic Disease
Inflammation
Eosinophilia
Sputum
1 Citation (Scopus)
Immunocompromised Host
Respiratory Insufficiency
Oxygen
Intubation
Mortality